A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Neonatal outcomes based on antenatal corticosteroid exposure time for infants delivered between 23 and 34 weeks gestation
2017
Clinical and experimental obstetrics & gynecology
able to receive a full course (≥ 48 hours to seven days) of ACS prior to delivery. With advances in both obstetrical and neonatal medicine, the present authors sought to determine a current minimal interval required from ACS administration to delivery to see an improvement in neonatal outcomes. Their primary hypothesis was that neonatal outcomes are improved prior to 48 hours after ACS administration. Materials and Methods This was a retrospective cohort study of all infants that delivered
doi:10.12891/ceog3469.2017
fatcat:5576ysahkbgylm6z2mnpfuusxi